Clinical features and underlying causes of cerebral venous thrombosis in Japanese patients

International Journal of Hematology

Volumn 99, Issue 4, 2014, Pages 437-440

  Shindo, Akihiro ^a   Wada, Hideo ^a   Ishikawa, Hidehiro ^a   Ito, Ai ^a   Asahi, Masaru ^a   Ii, Yuichiro ^a   Ikejiri, Makoto ^a   Tomimoto, Hidekazu ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Asia; Congenital thrombophilia; Prognosis; Protein C; Protein S

Indexed keywords

ANTITHROMBIN; HEPARIN; ORAL CONTRACEPTIVE AGENT; PROTEIN C; PROTEIN S; WARFARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACQUIRED THROMBOPHILIA; ADULT; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN DEFICIENCY; ANTITHROMBIN GENE; APHASIA; ARTICLE; BEHCET DISEASE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBRAL SINUS THROMBOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL THROMBOPHILIA; CONSCIOUSNESS DISORDER; CONTRAST ENHANCEMENT; DEEP VEIN THROMBOSIS; DEHYDRATION; DEMENTIA; DIGITAL SUBTRACTION ANGIOGRAPHY; DIZZINESS; FAMILY HISTORY; FEMALE; GAIT DISORDER; GENE; GENE MUTATION; GLASGOW COMA SCALE; HEADACHE; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; IRON DEFICIENCY ANEMIA; JAPANESE (PEOPLE); MALE; MOTOR NEUROPATHY; MULTIPLE ORGAN FAILURE; MYELODYSPLASTIC SYNDROME; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL THROMBOPLASTIN TIME; PHLEBOGRAPHY; PROGNOSIS; PROTEIN C DEFICIENCY; PROTEIN C GENE; PROTEIN S DEFICIENCY; PROTEIN S GENE; RANKIN SCALE; RETROSPECTIVE STUDY; SEIZURE; STRAIGHT SINUS; SUPERIOR SAGITTAL SINUS; THROMBOPHILIA; TRANSVERSE SINUS; VISUAL FIELD DEFECT; ADOLESCENT; AGED; BRAIN VEIN; CRANIAL SINUS; JAPAN; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME; VENOUS THROMBOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CEREBRAL VEINS; CRANIAL SINUSES; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84899657724     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-014-1550-x     Document Type: Article

References (31)

1. Guenther G, Arauz A. Cerebral venous thrombosis: a diagnostic and treatment update. Neurologia. 2011;26:488-98.
2. Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol. 2007;6:162-70. (Pubitemid 46097542)
3. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992;10:87-111.
4. Ogata T, Kamouchi M, Kitazono T, Kuroda J, Ooboshi H, Shono T, et al. Cerebral venous thrombosis associated with iron deficiency anemia. J Stroke Cerebrovasc Dis. 2008;17:426-8.
5. Shindo A, Ikejiri M, Ii Y, Nakatani K, Wada H, Nobori T, et al. A novel protein S gene mutation combined with protein S Tokushima mutation in a patient with superior sagittal sinus thrombosis. J Neurol. 2012;259:178-9.
6. Ikejiri M, Shindo A, Ii Y, Tomimoto H, Yamada N, Matsumoto T, et al. Frequent association of thrombophilia in cerebral venous sinus thrombosis. Int J Hematol. 2012;95:257-62.
7. Yoshikawa T, Abe O, Tsuchiya K, Okubo T, Tobe K, Masumoto T, et al. Diffusion-weighted magnetic resonance imaging of dural sinus thrombosis. Neuroradiology. 2002;44:481-8. (Pubitemid 36067839)
8. Van Swieten JC, Koudstall PJ, Visser MC, Shouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1989;19:604-7.
9. Ikejiri M, Tsuji A, Wada H, Sakamoto Y, Nishioka J, Ota S, et al. Analysis three abnormal protein S genes in a patient with pulmonary embolism. Thromb Res. 2010;125:529-32.
10. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306.
11. Teasdale G, Jannett B. Assessment of coma and impaired consciousness: a practical scale. Lancet. 1974;2:81.
12. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, for the ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664-70. (Pubitemid 38280838)
13. Canhão P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementaria F, for the ISCVT Investigators. Causes and predictors of death in cerebral venous thrombosis. Stroke. 2005;36:1720-5.
14. Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F, for the ISCVT Investigators. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke. 2005;36:1927-32.
15. Ferro JM, Lopes MG, Rosas MJ, Ferro MA, Fontes J, for the Cerebral Venous Thrombosis Portuguese Collaborative Study Group. Long-term prognosis of cerebral vein and dural sinus thrombosis: results of the VENOPORT study. Cerebrovasc Dis. 2002;13:272-8. (Pubitemid 34518723)
16. Ehtisham A, Stern BJ. Cerebral venous thrombosis: a review. Neurologist. 2006;12:32-8.
17. Simchen MJ, Goldstein G, Lubetsky A, Strauss T, Schiff E, Kenet G. Factor v Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke. Stroke. 2009;40:65-70.
18. Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, et al. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum. 2006;55:850-5. (Pubitemid 44917456)
19. Kottke-Marchant K, Duncan A. Antithrombin deficiency: issues in laboratory diagnosis. Arch Pathol Lab Med. 2002;126:1326-36. (Pubitemid 36237283)
20. Dahlbäck B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res. 1995;77:1-43.
21. Beauchamp NJ, Dykes AC, Parikh N, Campbell Tait R, Daly ME. The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol. 2004;125:647-54. (Pubitemid 38747968)
22. Griffin JH, Zlokovic BV, Mosnier LO. Protein C anticoagulant and cytoprotective pathways. Int J Hematol. 2012;95:333-45.
23. Segers K, Dhalbäck B, Nicolaes GA. Coagulation factor V and thrombophilia: background and mechanisms. Thromb Haemost. 2007;98:530-42. (Pubitemid 47412879)
24. Vicente V, González-Conejero R, Rivera J, Corral J. The prothrombin gene variant 20210A in venous and arterial thromboembolism. Haematologica. 1999;84:356-62. (Pubitemid 29474351)
25. Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol. 2002;70:126-32.
26. Takamiya O, Ishida F, Kodaira H, Kitano K. APC-resistance and Mnl I genotype (Gln 506) of coagulation factor V are rare in Japanese population. Thromb Haemost. 1995;74:996.
27. Miyata T, Kimura R, Kokubo Y, Sakata T. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol. 2006;83:217-23. (Pubitemid 44227995)
28. Kimura K, Honda S, Kawasaki T, Tsuji H, Madoiwa S, Sakata Y, et al. Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood. 2006;107:1737-8. (Pubitemid 43242422)
29. Neki R, Fujita T, Kokame K, Nakanishi I, Waguri M, Imayoshi Y, et al. Genetic analysis of patients with deep vein thrombosis during pregnancy and postpartum. Int J Hematol. 2011;94:150-5.
30. Sato R, Iwasawa M. Contraceptive use and induced abortion in Japan: how is it so unique among the developed countries? Jpn J Popul. 2006;4:33-54.
31. Khealani BA, Wasay M, Saadah M, Sultana E, Mustafa S, Khan FS, et al. Cerebral venous thrombosis: a descriptive multicenter study of patients in Pakistan and Middle East. Stroke. 2008;39:2707-11.